Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Chief Legal Officer Stephen P. Robertson sold 11,939 shares at $15.95 per share. The sale took place on September 10, 2026.
Autonomix Medical, Inc. (NASDAQ: AMIX) can raise up to $10.525 million by selling common stock through Ladenburg Thalmann & Co. Inc. The sales may occur from time to time through an at-the-market arrangement or in privately negotiated transactions. Ladenburg may act as the company’s …
Avalo Therapeutics, Inc. (NASDAQ: AVTX) CFO Sullivan Christopher Ryan exercised options for 10,185 shares at $8.04 per share on 10 September 2026.
BANK BRADESCO (NYSE: BBD) executive Paris Roberto de Jesus sold 25,000 shares at $18.50 per share. The transaction involved the company’s shares and was recorded on September 10, 2026.
BANK BRADESCO (NYSE: BBD) executive Scarpelli Cassiano Ricardo sold 70,000 shares at $18.50 per share.
BANC OF CALIFORNIA, INC. (NYSE: BANC) General Counsel Dotan Ido sold 10,541 shares at $18.30 per share. The transaction took place on September 10, 2026, and left Ido with 45,702 shares.
Van Sistine Peter J. sold 1,848 Bank First Corp (NASDAQ: BFC) shares at $155.57 per share on 11 September 2026. The director’s reported holding fell to 7,640 shares after the transaction.
Barinthus Biotherapeutics plc. is shown with a 0.0% position for Oxford Science Enterprises plc in a passive stake amendment.
AtaiBeckley Inc. (NASDAQ: ATAI) insider Robert Hershberg disposed of 741,089 derivative securities across five transactions on Sept. 11, 2026. His derivative-securities holding stood at zero after the transactions.
AtaiBeckley Inc. (NASDAQ: ATAI) insider JOHNSON SABRINA MARTUCCI disposed of 455,968 derivative securities. Following the transactions, the reported derivative-securities holding was 0.